胎儿心动过缓与长QT综合征的产前表现及结局
结果显示,无重大先天性心脏病或自身免疫病背景下持续性窦性心动过缓最常见的病因为长QT综合征。产前基因检测有助于父母咨询和孕期管理。
要点
- 无重大先心病或自身免疫病的持续性胎儿窦性心动过缓,最常见病因是长QT综合征。
- 胎儿窦性心动过缓、2:1房室传导阻滞和室性心动过速均可为长QT综合征的产前表现。
- N-LVIRT和LVIRT在多数病例中未超过阈值,但仍需未来研究进一步评估。
核心结论
- 无重大先天性心脏病或自身免疫病的持续性窦性心动过缓胎儿,最常见病因为长QT综合征。
- 产前基因检测可为父母咨询和孕期管理提供依据。
- N-LVIRT和LVIRT在多数病例中未超过阈值,但仍是未来研究的重要测量指标。
研究设计与样本
- 纳入表现为窦性心动过缓、非免疫性2:1房室传导阻滞或室性心动过速的胎儿。
- 排除母体抗Ro/抗La抗体阳性、房性早搏未下传及重大先天性心脏病病例。
主要发现
- 共纳入22例胎儿,16例表现为窦性心动过缓,2例为2:1房室传导阻滞,2例同时有窦性心动过缓和2:1房室传导阻滞,2例为室性心动过速。
- 14例进行了基因检测,其中12例为产前检测。
- 13例长QT综合征基因型阳性,包括8例KCNQ1、1例KCNE1、2例KCNH2、1例SCN5A和1例CALM2。
- 窦性心律时胎儿心率中位数为120次/分(范围100-139),心率Z评分中位数为-3.04(范围-4.98至-0.91)。
- 13例基因确诊长QT综合征病例中,N-LVIRT持续超过阈值的有2例,LVIRT持续超过阈值的有6例。
关键数值与推荐
- 胎儿心动过缓定义为心室率低于相应孕周均值的2个标准差以上。
- 窦性心律时胎儿心率中位数为120次/分(范围100-139)。
- 胎儿心率Z评分中位数为-3.04(范围-4.98至-0.91)。
- 13例长QT综合征基因型阳性,其中N-LVIRT超过阈值2例,LVIRT超过阈值6例。
临床怎么用
- 对无重大先心病或自身免疫病的持续性胎儿窦性心动过缓,应考虑长QT综合征的可能。
- 产前基因检测有助于明确诊断,指导父母咨询和妊娠期管理。
- N-LVIRT和LVIRT可作为评估胎儿QT间期的参考指标,但当前证据不足以作为独立诊断依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Fetal bradycardia may be defined as a ventricular rate more than 2 SD below the gestational-age-specific mean. Sinus bradycardia, functional 2:1 atrioventricular block (AVB) and/or polymorphic ventricular tachycardia (VT) are recognized as potential presentations of fetal long QT syndrome (LQTS). The objectives of this study were to describe the associations with LQTS and outcomes of fetuses presenting with isolated sinus bradycardia, 2:1 AVB or VT. METHODS: This was a retrospective review of all cases presenting with sinus bradycardia, non-immune mediated 2:1 AVB or VT on referral to our tertiary fetal cardiology center between January 2018 and November 2023. Cases with maternal anti-Ro/anti-La antibodies, blocked atrial ectopic beats or major congenital heart disease were excluded. Data were collected on patient demographics, fetal echocardiography findings, clinical genetic results, family screening and postnatal outcome. The left ventricular isovolumetric relaxation time (LVIRT) and LVIRT normalized as a proportion of cycle length (N-LVIRT) were derived using pulsed-wave Doppler tracings to estimate the QT interval. RESULTS: In total, 22 fetuses were included in the study, with a presenting rhythm of sinus bradycardia in 16, 2:1 AVB in two, both sinus bradycardia and 2:1 AVB in two and VT in two. None had a family history of LQTS. Genetic testing was performed in 14 cases of which 12 were tested prenatally. There were 13 cases with a positive LQTS genotype (eight KCNQ1, one KCNE1, two KCNH2, one SCN5A and one CALM2). Median presenting fetal heart rate (FHR) and FHR Z-score in sinus rhythm was 120 (range, 100-139) bpm and -3.04 (range, -4.98 to -0.91), respectively. In the 13 cases with genetically confirmed LQTS, N-LVIRT and LVIRT were persistently above threshold in two and six cases, respectively. CONCLUSIONS: The most common finding in fetuses with persistent sinus bradycardia without major congenital heart disease or autoimmune disease is LQTS. Prenatal genetic testing enables tailored parental counseling and management of the pregnancy. Although N-LVIRT and LVIRT were not above the threshold values in most cases, they remain important measures for investigation in future studies. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Chivers, Zidere, Vigneswaran, et al. Prenatal presentation of fetal bradycardia and long QT syndrome. Ultrasound Obstet Gynecol. 2026. PMID: 41482982. doi:10.1002/uog.70132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。